Diamantis, S.; Retur, N.; Bertrand, B.; Lieutier-Colas, F.; Carenco, P.; Mondain, V.; on behalf of PROMISE Professional Community Network on Antimicrobial Resistance.
The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics. Antibiotics 2022, 11, 924.
https://doi.org/10.3390/antibiotics11070924
AMA Style
Diamantis S, Retur N, Bertrand B, Lieutier-Colas F, Carenco P, Mondain V, on behalf of PROMISE Professional Community Network on Antimicrobial Resistance.
The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics. Antibiotics. 2022; 11(7):924.
https://doi.org/10.3390/antibiotics11070924
Chicago/Turabian Style
Diamantis, Sylvain, Nicolas Retur, Benjamin Bertrand, Florence Lieutier-Colas, Philippe Carenco, Véronique Mondain, and on behalf of PROMISE Professional Community Network on Antimicrobial Resistance.
2022. "The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics" Antibiotics 11, no. 7: 924.
https://doi.org/10.3390/antibiotics11070924
APA Style
Diamantis, S., Retur, N., Bertrand, B., Lieutier-Colas, F., Carenco, P., Mondain, V., & on behalf of PROMISE Professional Community Network on Antimicrobial Resistance.
(2022). The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics. Antibiotics, 11(7), 924.
https://doi.org/10.3390/antibiotics11070924